1Tsang TSM,Gersh BJ.Atrial fibrillation:an old disease,a new epidemic[J].Am J Med,2002,113:432-435.
2Le Heuzey JY,Aliot E,Jaillon P,et al.AFFIRM:what we have learned and pending issues[J].Ann Cardiol Angiol,2005,54(4):190-193.
3Wyse DG,Waldo AL,DiMarco JP,et al.A comparison of rate control and rhythm control in patients with atrial fibrillation[J].N Engl J Med,2002,347:1825-1833.
4Van Gelder IC,Hagens VE,Bosker HA,et al.A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation[J].N Engl J,2002,347:1834-1840.
5Curtis AB,Gersh BJ,Corley SD,et al.Clinical factors that influence response to treatment strategies in atrial fibrillation:the Atrial Fibrillation Follow-up Investigation of Rhythm Management(AFFIRM)study[J].Am Heart J,2005,149(4):645-649.
6Snow V,Weiss KB,LeFevre M,et al.Management of newly detected atrial fibrillation:a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians[J].Ann Intern Med,2003,139(12):1009-1017.
7EAFT(European Atrial Fibrillation Trial)Study Group.Secondary.prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke..Lancet[J],1993,342:1255-1262.
8Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation:a multicenter,prospective,randomized trial.Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group[J].Stroke,2000,31:817-821.
9Gage BF,Waterman AD,Shannon W,et al.Validation of clinical classification schemes for predicting stroke:results from the National Registry of Atrial Fibrillation[J].JAMA,2001,285:2864-2870.
10McNamara RL,Tamariz LJ,Segal JS,et al.Management of atrial fibrillation:review of the evidence for the role of pharmacologic therapy,electrical cardioversion,and echocardiography[J].Ann Intern Med,2003,139:1018-1033.
